A Clinical Trial to Determine the Effects of 40 Mg Doxycycline Versus a Placebo Control for the Treatment of Rosacea
Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety and efficacy of 40 mg doxycycline
controlled-release capsules administered once daily for the treatment of rosacea compared
with a placebo.